RMC No. 27-2026: Updated FDA List of VAT-Exempt Drugs for Cancer, Diabetes, Hypertension, and Other Illnesses

RMC No. 27-2026 updates the FDA-endorsed VAT-exempt drug list for cancer, diabetes, hypertension, kidney disease, mental illness, and more. Businesses selling covered medicines must immediately check whether their pharmacy, hospital, distribution, accounting, and point-of-sale systems reflect the updated VAT-exempt drug list endorsed by the Food and Drug Administration. RMC No. 27-2026 publishes the updated full […]

RMC No. 108-2025: Updated VAT-Exempt Drug List for Cancer, Diabetes, Hypertension, Kidney Disease, Mental Illness, Tuberculosis, and High Cholesterol

RMC No. 108-2025 updates the FDA-endorsed VAT-exempt drug list for key illnesses, affecting pharmacies, healthcare firms, and corporate tax teams. Businesses selling, importing, prescribing, purchasing, reimbursing, or accounting for qualified medicines must immediately validate their product master files, invoices, VAT treatment, and reimbursement rules against the updated VAT-exempt drug list endorsed by the Food and […]

RMC No. 59-2025: VAT-Exempt Medicines List Updated for Cancer, Diabetes, Hypertension, Kidney Disease, and Tuberculosis Products

RMC No. 59-2025 updates VAT-exempt medicines for key diseases, with effectivity tied to FDA Advisory issuance and proper product validation. Businesses dealing in medicines for cancer, diabetes, hypertension, kidney disease, and tuberculosis must immediately check whether their covered products are included in the updated VAT-exempt medicines list endorsed by the Food and Drug Administration. RMC […]

RMC No. 68-2022: Updated VAT-Exempt Medicines List for Hypertension, Diabetes, Cancer, COVID-19 and Other Treatments

RMC No. 68-2022 updates the FDA-endorsed VAT-exempt medicines list under CREATE for key disease categories including COVID-19 and cancer. Pharmacies, hospitals, clinics, distributors, importers, and VAT-registered sellers of medicines must check whether their covered products are included in the updated VAT-exempt medicines list endorsed by the Food and Drug Administration, because qualifying medicines for hypertension, […]

RMC No. 123-2021: Updated VAT-Exempt COVID-19 Medicines and Vaccine List for Pharmacies, Importers, Hospitals, and Healthcare Suppliers

RMC No. 123-2021 updates the VAT-exempt COVID-19 medicines and vaccine list, affecting pharmacies, hospitals, importers, and healthcare suppliers. Pharmacies, hospitals, healthcare suppliers, importers, distributors, wholesalers, and retailers dealing in COVID-19 medicines must immediately check their product master lists, invoices, point-of-sale systems, and importation records against the updated VAT-exempt list published under RMC No. 123-2021. The […]

RMC No. 62-2020: VAT-Exempt Prescription Drugs for Diabetes, High Cholesterol and Hypertension Starting January 27, 2020

RMC No. 62-2020 lists VAT-exempt prescription drugs for diabetes, high cholesterol, and hypertension effective January 27, 2020. Pharmacies, hospitals, clinics, importers, distributors, and VAT-registered sellers must treat only the listed prescription drugs and medicines for diabetes, high cholesterol, and hypertension as VAT-exempt beginning January 27, 2020. The key business consequence of RMC No. 62-2020 is […]